Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Jak2-Stat5 interactions analyzed in yeast

F Barahmand-Pour1, A Meinke, B Groner

  • 1Institute of Microbiology and Genetics, Vienna Biocenter, University of Vienna, Dr. Bohr-Gasse 9, A-1030 Vienna, Austria.

The Journal of Biological Chemistry
|June 20, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First-line ET plus palbociclib versus standard mono-chemotherapy in high-risk HR-positive/HER2-negative metastatic breast cancer and indication for chemotherapy: primary results from the randomized phase IV PADMA study.

ESMO open·2026
Same author

Unmet need for patients with metastatic triple-negative breast cancer initiating first-line treatment: data from the prospective German tumor registry OPAL.

ESMO real world data and digital oncology·2026
Same author

Final results of the INFINITY precision oncology registry: non-standard targeted treatments in patients with advanced cancers in routine care.

ESMO real world data and digital oncology·2026
Same author

Risk of disease progression in first-line metastatic colorectal cancer therapy to guide disease reassessments-analysis of 11 trials by AIO and GONO.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Conditional progression-free survival in patients with metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with first-line ribociclib and endocrine therapy: real-world data from the RIBANNA study.

ESMO open·2025
Same author

Impact of primary tumor sidedness and sex on prognosis and anti-epidermal growth factor receptor antibody efficacy in BRAF-mutant metastatic colorectal cancer: a pooled analysis of AIO studies FIRE-1, CIOX, FIRE-3, XELAVIRI, and VOLFI.

ESMO open·2024
Same journal

Wanted and unwanted modifications of mRNA, and their effect on gene expression and signaling.

The Journal of biological chemistry·2026
Same journal

TGF-β2 drives lipid droplet accumulation in chondrocytes through the TβRI/p-Smad3/Fabp5 axis.

The Journal of biological chemistry·2026
Same journal

Macrophage-specific targeting of histone demethylases with small-molecule inhibitors suppresses inflammatory response in vivo.

The Journal of biological chemistry·2026
Same journal

Substrate and target selectivity of 4'-fluoroadenosine against viral and host polymerases.

The Journal of biological chemistry·2026
Same journal

Correction: Characterization of Mast2 kinase defines structural features, regulation, and substrates.

The Journal of biological chemistry·2026
Same journal

Isotope-Edited ESEEM: A New Method for Probing Copper Binding Sites in Neurodegenerative Proteins.

The Journal of biological chemistry·2026
See all related articles

Yeast models effectively study Janus kinase (Jak) and signal transducer and activator of transcription (Stat) interactions. Mutational analysis reveals the Stat5 SH2 domain is crucial for Jak2 interaction, while Jak2

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Biochemistry

Background:

  • Cytokine receptors utilize Janus protein tyrosine kinases (Jaks) and signal transducers and activators of transcription (Stats) for nuclear signaling.
  • Understanding Jak-Stat pathway regulation is crucial for various cellular processes.

Purpose of the Study:

  • To establish and utilize yeast strains for analyzing Jak2 and Stat5 interactions.
  • To investigate the functional domains of Jak2 and Stat5 involved in their interaction and signaling.

Main Methods:

  • Construction of engineered yeast strains expressing autoactivated Jak2 and Stat5.
  • Co-immunoprecipitation to assess protein complex stability.
  • Site-directed mutagenesis and domain deletions to analyze protein function.

Related Experiment Videos

Main Results:

  • Yeast strains successfully reconstituted Jak2-induced Stat5 phosphorylation, dimerization, nuclear translocation, and DNA binding.
  • Jak2 kinase domain (JH1) was sufficient for Jak2-Stat5 interaction, while JH2 deletion enhanced activity.
  • Stat5 SH2 domain mutation (R618K) abolished phosphorylation; C-terminal deletion led to hyperphosphorylation.
  • Single phosphotyrosine-SH2 domain interaction enabled Stat5 dimerization but resulted in inefficient DNA binding.

Conclusions:

  • Yeast serves as a suitable model system for studying Jak-Stat and Stat-Stat interactions.
  • The Stat5 SH2 domain is essential for Jak2 interaction.
  • The Jak2 kinase domain is sufficient for initiating Stat5 phosphorylation, independent of receptor docking.